MultiPlan Co. (NYSE:MPLN) Receives $9.20 Average Target Price from Brokerages

MultiPlan Co. (NYSE:MPLN) has been given an average recommendation of “Buy” by the six ratings firms that are covering the company, MarketBeat reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is $9.20.

Several research analysts have recently weighed in on the stock. Zacks Investment Research cut shares of MultiPlan from a “hold” rating to a “sell” rating in a research report on Wednesday, August 11th. Tigress Financial assumed coverage on shares of MultiPlan in a research report on Friday, August 20th. They set a “buy” rating and a $9.00 price target on the stock.

MPLN traded up $0.05 on Tuesday, hitting $5.81. 2,354,841 shares of the company’s stock were exchanged, compared to its average volume of 2,807,027. MultiPlan has a fifty-two week low of $5.48 and a fifty-two week high of $11.48. The company has a current ratio of 2.52, a quick ratio of 2.52 and a debt-to-equity ratio of 2.09. The firm has a 50-day moving average price of $6.73 and a 200-day moving average price of $7.20. The stock has a market cap of $3.88 billion and a price-to-earnings ratio of -10.75.

In related news, Director Julie D. Klapstein acquired 12,000 shares of the stock in a transaction dated Friday, August 20th. The stock was acquired at an average cost of $6.00 per share, with a total value of $72,000.00. Following the completion of the transaction, the director now owns 30,105 shares in the company, valued at approximately $180,630. The purchase was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 17.70% of the company’s stock.

A number of institutional investors and hedge funds have recently made changes to their positions in MPLN. Capula Management Ltd acquired a new position in MultiPlan in the first quarter valued at approximately $57,000. Comerica Bank acquired a new stake in shares of MultiPlan in the second quarter valued at approximately $64,000. Twinbeech Capital LP acquired a new stake in shares of MultiPlan in the first quarter valued at approximately $87,000. Nisa Investment Advisors LLC purchased a new stake in shares of MultiPlan during the second quarter worth approximately $87,000. Finally, UBS Group AG raised its stake in shares of MultiPlan by 63.6% during the first quarter. UBS Group AG now owns 16,400 shares of the company’s stock worth $91,000 after purchasing an additional 6,375 shares during the last quarter. 84.24% of the stock is owned by hedge funds and other institutional investors.

About MultiPlan

MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services, which reduce medical costs through data-driven algorithms that detect claims over-charges and recommend or negotiate reimbursement; network-based services that reduce medical costs through contracted discounts with healthcare providers; and payment integrity services, which reduce medical costs by identifying and removing improper and unnecessary charges paid during the claim.

Read More: High-Yield Dividend Stocks

Receive News & Ratings for MultiPlan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MultiPlan and related companies with's FREE daily email newsletter.